TIS 0.00% 0.0¢ tissue therapies limited

CroMagnon, I have just received the following response from Dr...

  1. 1,824 Posts.
    lightbulb Created with Sketch. 4
    CroMagnon,

    I have just received the following response from Dr Brian Ziegelaar in relation to Prof. Keith Harding:-

    "Professor Harding is still involved, we have ongoing dialogue for developing programs to help commercialise VitroGro®ECM with the Welsh Wound Innovation Initiative. The aim of these programs is to work with Prof. Harding to expand the use of VitroGro®ECM in order to help patients suffering with Venous Leg Ulcers in the United Kingdom."

    Regards................................
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.